How I treat nodular lymphocyte-predominant Hodgkin lymphoma
DA Eichenauer, A Engert - Blood, The Journal of the American …, 2020 - ashpublications.org
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity
with distinct pathologic and clinical characteristics. Unlike the malignant cells in classical …
with distinct pathologic and clinical characteristics. Unlike the malignant cells in classical …
Pitfalls in the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma: variant patterns, borderlines and mimics
S Younes, RB Rojansky, JR Menke, D Gratzinger… - Cancers, 2021 - mdpi.com
Simple Summary Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare
lymphoma containing infrequent tumor cells (LP cells) in a background of non-neoplastic …
lymphoma containing infrequent tumor cells (LP cells) in a background of non-neoplastic …
Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma — All StAGEs: A consensus‐based position paper from …
A Shankar, GW Hall, P McKay… - British Journal of …, 2022 - Wiley Online Library
A consensus statement for the management for patients of all ages with all stages of nodular
lymphocyte predominant Hodgkin lymphoma (NLPHL)—All St AGE s—is proposed by …
lymphocyte predominant Hodgkin lymphoma (NLPHL)—All St AGE s—is proposed by …
Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working …
AC Lo, A Major, L Super, B Appel, A Shankar… - Leukemia & …, 2022 - Taylor & Francis
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin
lymphoma (HL) in both children and adults. In contrast to classic HL, NLPHL nearly always …
lymphoma (HL) in both children and adults. In contrast to classic HL, NLPHL nearly always …
Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies
DA Eichenauer, I Bühnen, C Baues, C Kobe, H Kaul… - Blood, 2023 - ashpublications.org
The optimal first-line treatment for nodular lymphocyte-predominant Hodgkin lymphoma
(NLPHL) diagnosed in early stages is largely undefined. We, therefore, analyzed 100 …
(NLPHL) diagnosed in early stages is largely undefined. We, therefore, analyzed 100 …
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
MS Binkley, JE Flerlage, KJ Savage… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL) is a rare cancer,
and large international cooperative efforts are needed to evaluate the significance of clinical …
and large international cooperative efforts are needed to evaluate the significance of clinical …
Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma with
sparse tumor B-cells and a favorable prognosis. Variant growth patterns of NLPHL, however …
sparse tumor B-cells and a favorable prognosis. Variant growth patterns of NLPHL, however …
Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management
SM Ansell - American journal of hematology, 2022 - Wiley Online Library
Abstract Disease Overview Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid
malignancy affecting 8540 new patients annually and representing approximately 10% of all …
malignancy affecting 8540 new patients annually and representing approximately 10% of all …
Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Clinicopathologic Reappraisal in the Modern Era
Abstract Objectives Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) differs
from classic Hodgkin lymphoma (CHL) in terms of clinicopathologic features, including …
from classic Hodgkin lymphoma (CHL) in terms of clinicopathologic features, including …
Nodular lymphocyte-predominant Hodgkin lymphoma: current management strategies and evolving approaches to individualize treatment
DA Eichenauer, S Hartmann - Expert Review of Hematology, 2023 - Taylor & Francis
ABSTRACT Introduction Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a
rare lymphoma entity accounting for roughly 5% of all Hodgkin lymphoma (HL) cases. In …
rare lymphoma entity accounting for roughly 5% of all Hodgkin lymphoma (HL) cases. In …